Resuming hip and knee arthroplasty after COVID-19: ethical implications for wellbeing, safety and the economy
- PMID: 32635761
- PMCID: PMC7345437
- DOI: 10.1177/1120700020941232
Resuming hip and knee arthroplasty after COVID-19: ethical implications for wellbeing, safety and the economy
Abstract
Reinstating elective hip and knee arthroplasty services presents significant challenges. We need to be honest about the scale of the obstacles ahead and realise that the health challenges and economic consequences of the COVID-19 pandemic are potentially devastating.We must also prepare to make difficult ethical decisions about restarting elective hip and knee arthroplasty. These decisions should be based on the existing evidence-base, reliable data, the recommendations of experts, and regional circumstances.
Keywords: COVID-19; Coronavirus disease 2019; SARS-CoV-2; coronavirus 2; economic; ethical challenge; healthcare; orthopaedic; revision arthroplasty; severe acute respiratory syndrome; total hip arthroplasty; total knee arthroplasty.
Conflict of interest statement
Figures
References
-
- Learmonth ID, Young C, Rorabeck C. The operation of the century: total hip replacement. Lancet 2007; 370: 1508–1519. - PubMed
-
- Laupacis A, Bourne R, Rorabeck C, et al. The effect of elective total hip replacement on health-related quality of life. J Bone Joint Surg Am 1993; 75: 1619–1626. - PubMed
-
- Canovas P, Dagneaux L. Quality of life after total knee arthroplasty. Orthop Traumatol Surg Res 2018; 104: S41–S46. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
